147 related articles for article (PubMed ID: 33151378)
1. Long-term cancer surveillance: results from the Forteo Patient Registry Surveillance Study.
Gilsenan A; Harris D; Reynolds M; McSorley D; Midkiff K; Jackson L; Muldavin B; Kellier-Steele N; Andrews E
Osteoporos Int; 2021 Apr; 32(4):645-651. PubMed ID: 33151378
[TBL] [Abstract][Full Text] [Related]
2. The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years.
Gilsenan A; Harding A; Kellier-Steele N; Harris D; Midkiff K; Andrews E
Osteoporos Int; 2018 Oct; 29(10):2335-2343. PubMed ID: 29978254
[TBL] [Abstract][Full Text] [Related]
3. Assessing the incidence of osteosarcoma among teriparatide-treated patients using linkage of commercial pharmacy and state cancer registry data, contributing to the removal of boxed warning and other labeling changes.
Kellier-Steele N; Casso D; Anderson A; Oliveria SA; Motsko S
Bone; 2022 Jul; 160():116394. PubMed ID: 35318162
[TBL] [Abstract][Full Text] [Related]
4. Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study.
Gilsenan A; Midkiff K; Harris D; Kellier-Steele N; McSorley D; Andrews EB
J Bone Miner Res; 2021 Feb; 36(2):244-251. PubMed ID: 32990990
[TBL] [Abstract][Full Text] [Related]
5. Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data.
Gilsenan A; Midkiff K; Harris D; McQuay L; Hunter S; Kellier-Steele N; Andrews E
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1616-1626. PubMed ID: 32894794
[TBL] [Abstract][Full Text] [Related]
6. The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years.
Andrews EB; Gilsenan AW; Midkiff K; Sherrill B; Wu Y; Mann BH; Masica D
J Bone Miner Res; 2012 Dec; 27(12):2429-37. PubMed ID: 22991313
[TBL] [Abstract][Full Text] [Related]
7. Of mice and men: divergent risks of teriparatide-induced osteosarcoma.
Subbiah V; Madsen VS; Raymond AK; Benjamin RS; Ludwig JA
Osteoporos Int; 2010 Jun; 21(6):1041-5. PubMed ID: 19597911
[TBL] [Abstract][Full Text] [Related]
8. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
9. Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008.
Duong LM; Richardson LC
J Registry Manag; 2013; 40(2):59-64. PubMed ID: 24002129
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
11. Incidence and survival rates among pediatric osteogenic sarcoma cases in Khon Kaen, Thailand, 1985-2010.
Wiromrat P; Jetsrisuparb A; Komvilaisak P; Sirichativapee W; Kamsa-Ard S; Wiangnon S
Asian Pac J Cancer Prev; 2012; 13(9):4281-4. PubMed ID: 23167328
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
13. Teriparatide and Osteosarcoma Risk: History, Science, Elimination of Boxed Warning, and Other Label Updates.
Krege JH; Gilsenan AW; Komacko JL; Kellier-Steele N
JBMR Plus; 2022 Sep; 6(9):e10665. PubMed ID: 36111201
[TBL] [Abstract][Full Text] [Related]
14. Second Primary Malignancies of the Bones and Joints: More Common than Expected in Osteosarcoma Patients.
Freedman IG; Dowd HN; Dhodapkar MM; Halperin SJ; Grauer JN
J Am Acad Orthop Surg Glob Res Rev; 2023 Jan; 7(1):. PubMed ID: 36695170
[TBL] [Abstract][Full Text] [Related]
15. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
16. Bone sarcoma incidence in the Netherlands.
Goedhart LM; Ho VKY; Dijkstra PDS; Schreuder HWB; Schaap GR; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Suurmeijer AJH; Jutte PC
Cancer Epidemiol; 2019 Jun; 60():31-38. PubMed ID: 30903831
[TBL] [Abstract][Full Text] [Related]
17. Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients.
Virtanen A; Pukkala E; Auvinen A
Int J Cancer; 2006 Feb; 118(4):1017-21. PubMed ID: 16152578
[TBL] [Abstract][Full Text] [Related]
18. Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958.
Rockberg J; Bach BA; Amelio J; Hernandez RK; Sobocki P; Engellau J; Bauer HC; Liede A
J Bone Joint Surg Am; 2015 Nov; 97(21):1756-66. PubMed ID: 26537163
[TBL] [Abstract][Full Text] [Related]
19. Regional variation and challenges in estimating the incidence of giant cell tumor of bone.
Liede A; Bach BA; Stryker S; Hernandez RK; Sobocki P; Bennett B; Wong SS
J Bone Joint Surg Am; 2014 Dec; 96(23):1999-2007. PubMed ID: 25471915
[TBL] [Abstract][Full Text] [Related]
20. [Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological Cancer Registry of North Rhine-Westphalia].
Kajüter H; Geier AS; Wellmann I; Krieg V; Fricke R; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):52-9. PubMed ID: 24357173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]